These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26690081)

  • 1. Modelling the consequences of a reduction in alcohol consumption among patients with alcohol dependence based on real-life observational data.
    Rahhali N; Millier A; Briquet B; Laramée P; Aballéa S; Toumi M; François C; Rehm J; Daeppen JB
    BMC Public Health; 2015 Dec; 15():1271. PubMed ID: 26690081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A predictive microsimulation model to estimate the clinical relevance of reducing alcohol consumption in alcohol dependence.
    François C; Laramée P; Rahhali N; Chalem Y; Aballéa S; Millier A; Bineau S; Toumi M; Rehm J
    Eur Addict Res; 2014; 20(6):269-84. PubMed ID: 25228120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol Consumption and Risk of Hospitalizations and Mortality in the Atherosclerosis Risk in Communities Study.
    Daya NR; Rebholz CM; Appel LJ; Selvin E; Lazo M
    Alcohol Clin Exp Res; 2020 Aug; 44(8):1646-1657. PubMed ID: 32524620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Trial-Based Predictive Microsimulation Assessing the Public Health Benefits of Nalmefene and Psychosocial Support for the Reduction of Alcohol Consumption in Alcohol Dependence.
    Laramée P; Millier A; Rahhali N; Cristeau O; Aballéa S; François C; Chalem Y; Toumi M; Rehm J
    Appl Health Econ Health Policy; 2016 Aug; 14(4):493-505. PubMed ID: 27283839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in non-abstinent WHO drinking risk levels and alcohol dependence: a 3 year follow-up study in the US general population.
    Hasin DS; Wall M; Witkiewitz K; Kranzler HR; Falk D; Litten R; Mann K; O'Malley SS; Scodes J; Robinson RL; Anton R;
    Lancet Psychiatry; 2017 Jun; 4(6):469-476. PubMed ID: 28456501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical health and drinking among medical inpatients with unhealthy alcohol use: a prospective study.
    Williams EC; Palfai T; Cheng DM; Samet JH; Bradley KA; Koepsell TD; Wickizer TM; Heagerty PJ; Saitz R
    Alcohol Clin Exp Res; 2010 Jul; 34(7):1257-65. PubMed ID: 20477765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol Consumption and Inpatient Health Service Utilization in a Cohort of Patients With Alcohol Dependence After 20 Years of Follow-up.
    Miquel L; Gual A; Vela E; Lligoña A; Bustins M; Colom J; Rehm J
    Alcohol Alcohol; 2017 Mar; 52(2):227-233. PubMed ID: 28182212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparison of Markov and Discrete-Time Microsimulation Approaches: Simulating the Avoidance of Alcohol-Attributable Harmful Events from Reduction of Alcohol Consumption Through Treatment of Alcohol Dependence.
    Laramée P; Millier A; Brodtkorb TH; Rahhali N; Cristeau O; Aballéa S; Montgomery S; Steeves S; Toumi M; Rehm J
    Clin Drug Investig; 2016 Nov; 36(11):945-956. PubMed ID: 27470429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting severe alcohol use disorders in primary care using number of heavy drinking days.
    Metz VE; Palzes VA; Kline-Simon AH; Chi FW; Weisner CM; Sterling SA
    Addiction; 2022 Nov; 117(11):2847-2854. PubMed ID: 35852025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Health Risk drinking and problematic consumption of alcohol in Pomerania: comparative analysis of the Study of Health in Pomerania (SHIP) compared with the Federal German Health and Examination Survey in 1998].
    Baumeister SE; Alte D; Meyer C; John U
    Gesundheitswesen; 2005 Jan; 67(1):39-47. PubMed ID: 15672305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence.
    Laaksonen E; Koski-Jännes A; Salaspuro M; Ahtinen H; Alho H
    Alcohol Alcohol; 2008; 43(1):53-61. PubMed ID: 17965444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study.
    van den Brink W; Sørensen P; Torup L; Mann K; Gual A;
    J Psychopharmacol; 2014 Aug; 28(8):733-44. PubMed ID: 24671340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressants for the treatment of people with co-occurring depression and alcohol dependence.
    Agabio R; Trogu E; Pani PP
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008581. PubMed ID: 29688573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sociodemographic and clinical factors associated with transdermal alcohol concentration from the SCRAM biosensor among persons living with and without HIV.
    Richards VL; Liu Y; Orr J; Leeman RF; Barnett NP; Bryant K; Cook RL; Wang Y
    Alcohol Clin Exp Res; 2021 Sep; 45(9):1804-1811. PubMed ID: 34342009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Relationship Between End-of-Treatment Alcohol Use and Subsequent Healthcare Costs: Do Heavy Drinking Days Predict Higher Healthcare Costs?
    Aldridge AP; Zarkin GA; Dowd WN; Bray JW
    Alcohol Clin Exp Res; 2016 May; 40(5):1122-8. PubMed ID: 27110675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WHO/ISBRA Study on State and Trait Markers of Alcohol Use and Dependence: analysis of demographic, behavioral, physiologic, and drinking variables that contribute to dependence and seeking treatment. International Society on Biomedical Research on Alcoholism.
    Glanz J; Grant B; Monteiro M; Tabakoff B;
    Alcohol Clin Exp Res; 2002 Jul; 26(7):1047-61. PubMed ID: 12170115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials.
    Falk DE; O'Malley SS; Witkiewitz K; Anton RF; Litten RZ; Slater M; Kranzler HR; Mann KF; Hasin DS; Johnson B; Meulien D; Ryan M; Fertig J;
    JAMA Psychiatry; 2019 Apr; 76(4):374-381. PubMed ID: 30865232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of non-consumption outcome measures in alcohol use disorder treatment.
    Kirouac M; Witkiewitz K
    Addiction; 2019 Jun; 114(6):1086-1092. PubMed ID: 30650471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the Tail Wag the Dog? Abstainers, Alcohol Dependence, Heavy Episodic Drinkers and Total Alcohol Consumption.
    Poikolainen K
    Alcohol Alcohol; 2017 Jan; 52(1):80-83. PubMed ID: 27810847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.